Delivery Order SPE2DB20D2002-SPE2DB24FL23G

Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of 4560732432 - Ondansetron ODT 4 mg tablets in 30-count packages, with a ceiling value of $3,198.00 and a completion date of April 27, 2023. This delivery order is part of a broader IDC that provides a comprehensive range of pharmaceutical products and...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The order is for 4,561,076,878 units of the prescription drug Ondansetron ODT 4 mg Tablet, at a ceiling value of $1,041.90. The contract is a firm fixed-price delivery order with a completion date of May 31, 2023. The contract award was not designated with a set-aside....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,561,836,511 Ondansetron ODT 8 mg tablets in 30-count packages. The contract has a ceiling value of $8,326.10 and a completion date of August 17, 2023. The contract is a firm-fixed-price Delivery Order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,617,621 units of the prescription drug Ondansetron ODT 8 mg tablets. The total ceiling value of the contract is $11,449.60, with a firm fixed price pricing type. The contract is not set aside and has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,255,117 units of Ondansetron ODT 4 mg tablets. The firm-fixed-price contract has a ceiling value of $3,609.81 and a completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,405,739 units of the medication Ondansetron ODT 8 mg Tablet, with a ceiling value of $7,802.08. The contract is a firm fixed-price delivery order with an ultimate completion date of August 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,469,416 units of the prescription drug Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $1,735.60 and a period of performance through August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of 4,565,446,703 units of Ondansetron ODT 4 MG Tablets (30s). The order is a firm fixed-price contract with a ceiling value of $7,999.00 and an ultimate completion date of August 15, 2024. Amerisourcebergen, a large pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $5,612.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,401,649 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,829.65, is for the delivery of 4,566,614,554 units of Ondansetron ODT 8 MG Tablets in 30-count packages. The contract has a firm fixed price and an ultimate completion date of December 5, 2024. This delivery order is part of a larger Indefinite Delivery...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL23G
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) as part of an Indefinite Delivery Contract (IDC) valued at $999,999,999 through November 2026. The order is for 4,563,605,858 units of the medication Ondansetron ODT 8 mg Tablets in a 30-count package, with a firm fixed price of $1,621.15 and a completion date of February 9, 2024. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly the military healthcare system. This delivery order supports the DLA's provision of essential pharmaceutical and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/27/25, 12:14 PM